Next-gen Compute
Hover to explore →
- 'Picks and shovels' of AI
- Next-gen memory and storage
- Automation of chip design
Triatomic Capital is a research-driven venture firm that invests in transformative technology companies from their earliest stages.
Headquartered in Palo Alto with a global investment mandate, we bring a deeply collaborative approach to partnering with visionary founders.
We form views through original research, often before a market exists to validate them.
A focused portfolio allows us to be substantive partners to every company we back.
Lead or follow, we look for deeply technical founders with a prescient vision of the future.
Our name honors H3+, the triatomic hydrogen ion, a molecule fundamental to the chemistry of the universe.
“...the molecule known as a triatomic hydrogen ion, or H3+, may hold secrets of the formation of the first stars after the Big Bang.”
“...the H3+ ion is the most prevalent molecular ion in interstellar space. It's also one of the most important molecules in existence.”
“Believed to be critical to the formation of stars in the early days of the universe, H3+ also is the precursor to many types of chemical reactions ... including those leading to compounds such as water or carbon, which are essential for life.”
Source: H3+: The molecule that made the Universe
Our team brings together decades of experience building and investing in transformative companies.
Jeff Huber
General Partner
Jeff Huber is the Founding CEO of GRAIL, whose mission is to detect cancer early, when it can be cured. He is also Co-Founder and President of OpenCovidScreen, a non-profit catalyzing innovation in fast, frequent, and low-cost COVID-19 testing.
Prior to GRAIL, Jeff was a Senior Vice President at Google for 13 years, where he co-founded Google's life sciences efforts in Google[x] (2013-2016) and led development for Google Maps, Google Apps, and Google Ads. During his tenure he oversaw 50x revenue growth (from $1B to over $50B) and managed distributed teams of 5,000+. Earlier, Jeff led engineering and product at eBay and Excite@Home.
Jeff serves on the boards of Mammoth Biosciences, Electronic Arts, Upstart, Openwater, Genalyte (Chairman), and the Parker Institute for Cancer Immunotherapy. He is a former board member of GRAIL, Aldevron, Ancestry.com, Weta Digital, and Illumina. Jeff holds a B.S. in Computer Engineering from the University of Illinois and an M.B.A. from Harvard Business School.
Peter Zhou
General Partner
Prior to co-founding Triatomic, Peter invested in technology and healthcare companies across all stages for over 15 years. Between 2010 and 2020, Peter was a Senior Managing Director at Coatue Management where he managed public and private investments across tech, healthcare, consumer, and other sectors. Previously, Peter was an Analyst in the Corporate Private Equity group at Blackstone, where he worked on transactions in both the US and Asia. Peter sits on the Board of Trustees of the Cancer Research Institute, one of the first backers of cancer immunotherapy research. Peter graduated from Harvard University in 2007 with a degree in Economics.
Steve Hochberg
General Partner
Steve Hochberg has been a founder, manager, and investor in HealthTech and Healthcare companies for over thirty years. The first company he co-founded in the early '90s was Physicians' Online. Since then, he founded or co-founded more than thirty additional companies. From 2013-2022, Steve was a Partner at Deerfield Management, where he focused on structured transactions across seed, growth, and late stage investments in MedTech, HealthTech, and Services.
In 2006, Steve became a founding Board Member of SLR Capital, an $12B family of BDCs. In 2011, Steve became Chairman of Continuum Health Partners and led its merger with Mount Sinai in 2013, where he is now Vice Chairman of the Mount Sinai Health System, a non-profit with over $12B in annual revenues.
Steve holds a B.S. in Business Administration from the University of Michigan and an M.B.A. from Harvard Business School.
Dhruv Bavaria
Chief Financial Officer
Dhruv leads finance at Triatomic. He has spent more than two decades building and running finance functions for venture capital, private equity, and family office organizations. Prior to joining Triatomic, Dhruv was Chief Financial Officer and Chief Compliance Officer at Selby Lane Capital, a boutique investment firm investing across venture capital, private equity, and growth equity. Before that, he was Chief Financial Officer at Soma Capital, an early-stage venture capital firm investing in software and technology companies. Earlier in his career, Dhruv was the first finance hire at ICONIQ Capital's Merchant Bank, where he built and led the team overseeing fund finance and valuations for the firm's alternative asset funds. Dhruv graduated from Cal Poly, San Luis Obispo in 2005 with a degree in Business Administration and is licensed as a Certified Public Accountant (inactive) in the State of California.
Benjamin Li
Head of International
Benjamin Li is Head of APAC at Triatomic Capital, responsible for deal sourcing, investor relations, and business development efforts in the region. Prior to Triatomic, Benjamin was a Managing Director at RAM AI, where he led corporate strategic development and international growth for Europe and Asia-Pacific between 2014 and 2020. He started his career with Deutsche Asset Management in 2007. Benjamin graduated from Cornell University with a B.S. in Economics and Psychology and earned his M.B.A. from IMD. In 2024, he became a member of the Cornell University Council.
Lauren Reyes
Executive Assistant
Lauren Reyes has over 17 years of experience in communications, the nonprofit sector, and tech. She has held high-level administrative and leadership roles at small nonprofit organizations throughout San Francisco and New Orleans. Prior to joining Triatomic Capital, she supported senior leaders across several go-to-market teams at Confluent as an Executive Assistant. She graduated from the University of California, Irvine with a BA in Psychology and Social Behavior.
Willem van den Bosch
Principal
Willem brings 8 cumulative years of combined operating and investing experience. Willem most recently came from Soma Capital, where he helped lead early stage investments in a broad array of early stage businesses, across SaaS, DeepTech, and FinTech. Prior to venture, Willem operated on DoorDash's Finance and Strategy team from pre-IPO and worked at a long-short hedge fund located in Los Angeles. Willem graduated with a double major in Economics and Political Science from University of California, Los Angeles.
Anh Wilson
Head of BD and Investor Relations
Anh brings a wealth of experience in business development and investor relations, grounded in a robust background within the financial industry. Her expertise encompasses marketing and relationship management, with a keen focus on addressing client needs and crafting innovative solutions. Throughout her career, Anh has played a key role in identifying capital formation opportunities, devising strategic growth plans, and forging enduring partnerships with investors and industry stakeholders in the alternative investments sector. She has extensive experience working with diverse institutional channels, including sovereign wealth funds, pension funds, insurance companies, endowments, foundations, and family offices. Anh's approach is characterized by a blend of leadership and collaboration, with a commitment to driving success, creating value, and fostering strong, productive relationships.
We invest in founders building foundational technologies across AI, biotech, energy, and infrastructure.

Gigascale manufacturing
Formal reasoning for AI

Real time data platform for AI applications

Digitizing chemistry for drug and material discovery

AI agent for complex work

In-memory compute for generative AI

Scientific superintelligence

Unmatched efficiency in computer processing

Scalable DNA synthesis for genetic medicine

Agent native inference cloud

AI networking at the speed of light

Supermaterial applications company

In-vivo therapeutics development platform

Accelerated compute for leading-edge LLMs
AI lab for general biological intelligence
The above companies represent the majority and not all companies in which Triatomic has invested. A list of all companies is available upon request.
Our view on where the most innovation will come from in the course of the coming decades.
Hover to explore →
Hover to explore →
Hover to explore →
Hover to explore →
Hover to explore →